Clinical Trial Update: Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

View source ↗

Summary

This clinical trial registry update describes a registry of participants with generalized myasthenia gravis treated with Alexion's C5 inhibition therapies (ecul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• SOLIRIS (eculizumab)
• ULTOMIRIS (ravulizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Generalized Myasthenia Gravis | Status: RECRUITING